Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Cristina Ligia, Cebotaru"'
Autor:
Diana Iordache, Anita-Andrea Kövendi, Zsolt Fekete, Raluca Popita, Iunia Patricia Cebotaru, Annamaria Patka, Ioana Cristina Năstase, Cristina Ligia Cebotaru
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 988-994 (2024)
Introduction: Clear cell sarcoma (CCS) of soft tissue is a rare type of soft tissue sarcoma affecting usually lower extremities in young adults. The main challenges in the management of this disease include difficulties in diagnosis, aggressiveness o
Externí odkaz:
https://doaj.org/article/75d4b394e08c4160a2f0eec5905e44a1
Autor:
Bernardo Garichochea, Judit Demeter, Yuankai Shi, Umberto Vitolo, Enrica Morra, Margarida Marques, Miklos Egyed, Toshiki Uchida, Árpád Illés, Kenichi Ishizawa, Cristina Ligia Cebotaru, Ashis Mukhopadhyay, Masafumi Taniwaki, Sung-Soo Yoon, Cristina-Ligia Truica, Cheol Won Suh, Irina Lysenko, Naokuni Uike, Huaqing Wang, Achiel Van Hoof, Maryna Kyselyova, Osmanov Ea, Andrew Belch, Alexy Kuzmin, Caballero Gabarrón, Steven Van Steenweghen, Sergio Cancelado, Olga Samoilova, Kensei Tobinai, Kiyoshi Ando, Susumu Nakahara, Tatiana Scheider, Massimo Federico, Dmitry Udovitsa, Xiaoyan Ke, Yurii Lorie, Tatsu Shimoyama, Weerasak Nawarawong, Sebastian Grosicki, Gregor Verhoef, Nuriet Khuageva, Suporn Chuncharune, Fritz Offner, Albert Oriol Rocafiguera, Charles Farber, Ernst Späth-Schwalbe, Juliana Pereira, Ting Liu, Lee-Yung Shih, Steven Le Gouill, Miklos Udvardy, Richard Greil, Carmen Cao, Tomohiro Kinoshita, Horia Bumbea, Yasuhito Terui, Eva Gonzalez-Barca, Irina Bulavina, Peter Hu, Francisco Javier Capote, Olga Serduk, Akihiro Tomita, Ilseung Choi, Mahmut Gumus, Udomsak Bunworasate, Adriana Teixeira, Vladimir Merkulov, Yeow Tee Goh, Tadeusz Robak, Huiqiang Huang, Jie Jin, Cristina Ileana Burcoveanu, Halyna Pylypenko, Joaquín Díaz, Herlander Marques, Zoltán Gasztonyi, Vijay Rao Phooshkooru, Gayane Tumyan, Maike De Wit, Ali Khojasteh, Marcelo Capra, Vladimir Lima, Dai Maruyama, Viacheslav Pavlov, Georg Heß, Carmino Antonio De Souza, Zhao Wang, Iryna Kryachok, Amel Mezlini, Galvez Cardenas, Marina Golubeva, Lyudmila Kuzina, Patricia Santi, Remy Gressin, Balkis Meddeb, Xiaonan Hong, David Belada, Bernard De Prijck, Jan Maciej Zaucha, Jiri Mayer, Michinori Ogura, Rumiko Okamoto, Dolores, Irit Avivi, Mario Ojeda-Uribe, Grigoriy B Rekhtman, Jun Zhu, Reyes Arranz, Polina Kaplan, André Bosly, Ann Van De Velde, Kenny Mauricio, Yuri Dunaev, Anatoly Golenkov, Oleg Gladkov, Yoshiharu Maeda, Franco Cavalli, Dina Ben Yehuda, Michele Baccarani, Markus Raderer, Razvan Stoia, Carlos Appiani, Zvenyslava Masliak, Zita Borbenyi, Guiseppe Rossi, Julia Alexeeva, Johannes Drach, Kateryna Vilchevskaya, Georgii Manikhas, Jan Novák, Noppadol Siritanaratkul, Zhixiang Shen, Alexander Suvorov, Michael Crump, Pierre Zachee, Ofer Shpilberg, Sepideh Nemat, Mitsutoshi Kurosawa, Sreejith Nair, Bulent Undar, Govind Babu, Kudrat Abdulkadryrov, Adriana Sheliga
Publikováno v:
The Lancet Oncology. 19:1449-1458
Summary Background In the LYM-3002 study, the efficacy and safety of frontline bortezomib plus rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) and rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) were c
Autor:
Corina E. Dutcus, David Miller, Olga N. Mikheeva, Cristina Ligia Cebotaru, Richard T. Penson, Agustin A. Garcia, Michael Teneriello, Ignace Vergote, Min Ren, Mariusz Bidziński, Yasuhiro Funahashi, Tadashi Kadowaki, Matthew A. Powell
Publikováno v:
Gynecologic oncology. 156(3)
OBJECTIVE: This study assessed the efficacy of lenvatinib, a multitargeted tyrosine kinase inhibitor, as second-line therapy in patients with unresectable endometrial cancer. The primary end point was the objective response rate (ORR) as assessed by
Circulating tumor cells in germ cell tumors: are those biomarkers of real prognostic value? A review
Autor:
Rares Buiga, Nicoleta Zenovia Antone, Cristina Ligia Cebotaru, Viorica Nagy, Elena Diana Olteanu
Publikováno v:
Clujul Medical
Analysis of circulating tumor cells from patients with different types of cancer is nowadays a fascinating new tool of research and their number is proven to be useful as a prognostic factor in metastatic breast, colon, and prostate patients. Studies
Autor:
Margitta Retz, Cristina Ligia Cebotaru, Sabine de Ducla, Umberto Basso, Zsuzsanna Kahán, Raymond S. McDermott, Anna Planas Lladó, Javier Puente, Giuseppe Luigi Banna, Florian Seseke, Cora N. Sternberg, Urbano Anido Herranz, Simon Fear, Ugo De Giorgi, Julie Pavlova, Wen Pin Su, Thomas Powles, Álvaro Montesa, Jacques De Greve
Publikováno v:
Journal of Clinical Oncology. 38:5036-5036
5036 Background: Atezo, which targets PD-L1, is an approved therapy for LA/M urothelial carcinoma based on the IMvigor210 and IMvigor211 trials. The single-arm SAUL study (NCT02928406) showed consistent activity and safety in a broader population, in
Autor:
Carmen, Georgiu, Iulian, Opincariu, Cristina Ligia, Cebotaru, Ştefan Claudiu, Mirescu, Bogdan Petre, Stănoiu, Teodora Ana Maria, Domşa, Alina Simona, Şovrea
Publikováno v:
Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie. 57(4)
Central nervous system (CNS) germ cell tumors are very rare, accounting for 0.3-3% of primary intracranial neoplasms; of these, the teratomas are even more uncommon. The immature variant of teratomas, defined by the presence of incompletely different
Autor:
Cristina, Ligia Cebotaru, Nicoleta, Zenovia Antone, Elena, Diana Olteanu, Nona, Bejinariu, Rares, Buiga, Nicolae, Todor, Dana, Ioana Iancu, Tudor, Eliade Ciuleanu, Viorica, Nagy
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 21(3)
One half of high-risk germ cell tumor (HRGCT) patients relapse after standard chemotherapy. This phase II study evaluated prospectively the toxicity and efficacy in first-line of the paclitaxel-ifosfamide-cisplatin combination (TIP) in HRGCT patients
Autor:
A. Casado Herraez, Cristina Ligia Cebotaru, Alfredo Zurlo, Riccardo Belli, Alla Lisyanskaya, Nicoletta Colombo, F. Raspagliesi, Jalid Sehouli, M. Romeo Marin, U. De Giorgi, Marcia Hall, S. Mihutiu, Róbert Póka, Janina Markowska, B. Zurawski, J.A. Arranz Arija, Jonathan A. Ledermann, N. Kovalenko, Susana Banerjee, E. Kutarska
Publikováno v:
Annals of Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Autor:
David Miller, Yasuhiro Funahashi, Agustin A. Garcia, Tadashi Kadowaki, Michael Teneriello, Richard T. Penson, James P. O'Brien, Cristina Ligia Cebotaru, Min Ren, Matthew A. Powell, Ignace Vergote, Mariusz Bidziński, Nicole Meneses, Olga N. Mikheeva, Tamás Pintér, Jean Fan
Publikováno v:
ResearcherID
David Scott Miller
Web of Science
David Scott Miller
Web of Science
5520 Background: Lenvatinib is an oral receptor tyrosine kinase inhibitor targeting VEGFR1-3, FGFR1-4, RET, KIT, and PDGFRβ. The importance of angiogenesis in endometrial cancer (EC) highlights the need to understand clinical mechanisms of escape (e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25fcc7d913d411d76edff47caf8fddcf
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000335419602034&KeyUID=WOS:000335419602034
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000335419602034&KeyUID=WOS:000335419602034